Affiliation:
1. Department of Cardiology, Joint Laboratory of Guangdong‐Hong Kong‐Macao Universities for Nutritional Metabolism and Precise Prevention and Control of Major Chronic Diseases The Eighth Affiliated Hospital of Sun Yat‐sen University Shenzhen China
2. Department of Radiotherapy Sun Yatsen Memorial Hospital, Sun Yat‐sen University Guangzhou Guangzhou China
Abstract
AbstractVarious digital therapeutic products have been validated and approved since 2017. They have demonstrated efficacy and safety as a new therapeutic modality in various disorders or conditions. Hypertension is a common but serious condition that can be prevented or controlled with lifestyle changes and medicines. Although a digital therapeutic in hypertension is validated and approved in Japan, whether digital therapeutics (DTx) can significantly improve sustainable lifestyle changes is still a controversial topic. Most studies did not discuss the long‐term gain challenges. In this review, the authors discuss the definition of DTx, and analyze the motivation, engagement and adherence challenges of DTx in hypertension. Some ongoing artificial intelligence (AI)‐enabled or cognitive behavioral therapy (CBT)‐based digital interventions and behavioral strategies for implementing sustainable lifestyle changes are identified and analyzed. With AI‐enabled interventions and behavioral strategies, DTx might be one of the effective approaches to make sustainable lifestyle changes.
Funder
National Basic Research Program of China
National Natural Science Foundation of China
Reference32 articles.
1. Lifestyle management of hypertension: International Society of Hypertension position paper endorsed by the World Hypertension League and European Society of Hypertension
2. SimonM.The emerging world of digital therapeutics.Nature.2019. Accessed May 30 2023.https://www.nature.com/articles/d41586‐019‐02873‐1
3. Digital Therapeutics Alliance.About DTA. Digital Therapeutics Alliance. Accessed May 30.https://dtxalliance.org/about‐dta
4. Digital Therapeutics in Hypertension: Evidence and Perspectives
5. International Organization for Standardization (ISO).ISO/TR 11147:2023 health informatics—personalized digital health—digital therapeutics health software systems.International Organization for Standardization (ISO).2023. Accessed Jul 20 2023.https://www.iso.org/standard/83767.html